SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
April 10, 2024 08:30 ET
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024...
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
April 01, 2024 16:00 ET
|
SANUWAVE Health, Inc.
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVE EDEN PRAIRIE, MN,...
SANUWAVE Announces Record Q4 and FY2023 Revenue
March 22, 2024 06:00 ET
|
SANUWAVE Health, Inc.
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 2023 compared to an operating...
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
March 20, 2024 07:00 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...